Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears CellaVision's automated cell locating device:

This article was originally published in Clinica

Executive Summary

Sweden's CellaVision has received US FDA 510(k) marketing clearance for its automated cell-locating device for the differential count of white blood cells and the characterisation of red morphology. The DiffMaster Octavia system is expected to go on sale during 2002, says Yvonne Martensson, CEO of the Lund-based, Sweden company.

Topics

UsernamePublicRestriction

Register

MT070791

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel